Table 2. Numbers of eyes in the vitrectomized and non-vitrectomized groups with IOP values of 25 mmHg or higher after receiving the first and second doses. In the non-vitrectomized group, IOP values of 25 mmHg or higher were recorded after the first dose in 13 eyes (8 with DME, 4 with BRVO, and 1 with uveitis) and after the second dose in 5 eyes (3 with DME, 1 with CRVO, and 1 with BRVO); in the vitrectomized group, IOP values of 25 mmHg or higher were recorded after the second dose in 2 eyes with DME.